文献速递糖尿病

妊娠期糖尿病孕妇的实时连续血糖监测:一项随机对照试验

Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes Mellitus: A Randomized Controlled Trial.
PubMed 文献 · Diabetes Care · 2025-01-01

该开放标签、单中心随机对照试验将111例≥20周的妊娠期糖尿病孕妇按2:1随机分为实时CGM联合CBG组(74例)与单纯CBG组(37例),主要结局为入组至分娩入院期间CGM 60-140 mg/dL的%TIR,CGM组显著高于对照组(93±6 vs 88±14,P=0.027)。作者结论为实时CGM较CBG监测可显著提高%TIR,但需研究更低的CGM血糖水平能否改善围产期和新生儿结局。

要点

  • 妊娠期糖尿病孕妇使用实时CGM较单纯CBG监测可显著提高60-140 mg/dL的%TIR。
  • CGM组日间TIR更高,24小时及日间平均血糖和>140 mg/dL时间百分比更低。
  • 作者指出需研究降低CGM血糖水平能否改善围产期和新生儿结局。

核心结论

  • 在妊娠期糖尿病孕妇中,实时CGM较CBG血糖监测可显著提高%TIR。
  • 作者指出需开展研究以确定实现更低的CGM血糖水平能否改善围产期和新生儿结局。

研究设计与样本

  • 开放标签、单中心、随机对照试验,纳入妊娠期糖尿病且孕周≥20周的孕妇。
  • 受试者按2:1随机分配至实时CGM联合辅助CBG组(74例)或单纯CBG组(37例),共111例,于2021年2月至2023年6月入组。
  • 干预组从入组至分娩入院期间持续使用Dexcom G6 CGM系统;对照组每日4次CBG监测,并在整个研究期间约每20天接受一次盲法CGM。
  • 主要结局为入组至分娩入院期间CGM 60-140 mg/dL(3.3-7.8 mmol/L)的%TIR。

主要发现

  • CGM组%TIR±SD显著高于对照组(93±6 vs 88±14,60-140 mg/dL,P=0.027)。
  • 两组人口学特征无统计学差异。
  • 在关键次要CGM指标中,干预组日间TIR显著更高,24小时及日间平均血糖和>140 mg/dL时间百分比显著低于对照组。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the efficacy of real-time continuous glucose monitoring (CGM; intervention) with capillary blood glucose (CBG) monitoring (control) alone to achieve greater percent glucose time in range (%TIR) among pregnant individuals diagnosed gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS: This was an open-label, single-center, randomized controlled trial of pregnant individuals with GDM and ≥20 weeks' gestation. Subjects were randomly assigned (2:1) to use real-time CGM plus adjunctive CBG versus CBG alone for glucose monitoring. The intervention group was instructed on the continuous use of the Dexcom G6 CGM system from enrollment to admission for delivery. The control group used CBG monitoring four times per day underwent blinded CGM approximately every 20 days throughout the study period. The primary outcome was the CGM %TIR defined as 60-140 mg/dL (3.3-7.8 mmol/L) from study enrollment until hospital admission for delivery. RESULTS: A total of 111 participants were enrolled between February 2021 and June 2023 (n = 74 in intervention group; n = 37 in control group) with no statistical differences in demographic characteristics between the groups. The CGM group had significantly higher %TIR ±SD (93 ± 6 min vs. 88 ± 14 min at 60-140 mg/dL; P = 0.027). Among key secondary CGM metric outcomes, the intervention group had significantly higher daytime TIR with lower 24-h and daytime mean glucose and percent time >140 mg/dL compared with the control group. CONCLUSIONS: We demonstrated a significantly higher %TIR using real-time CGM compared with CBG glucose monitoring among pregnant people with GDM. Studies are needed to determine if achieving lower CGM glucose levels can improve perinatal and neonatal outcomes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Valent AM, Rickert M, Pagan CH, et al. Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes Mellitus: A Randomized Controlled Trial. Diabetes Care. 2025. PMID: 40730104. doi:10.2337/dc25-0115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。